Human iPS cells are difficult to transfect at a high efficiency and it is difficult to maintain the undifferentiated status during electroporation.   

The Celetrix technology can electroporate human iPSC (e.g. ACS-1030 from ATCC) at a very high efficiency of more than 73%. Most of the cell survive well after electroporation.